A KIT FORMULATION FOR PREPARATION OF [IN-111]IN-DTPA-FOLATE, A FOLATE-RECEPTOR-TARGETED RADIOPHARMACEUTICAL

A kit formulation has been developed for convenient, routine compoundi ng of In-111-labeled In(III)-DTPA-Folate, an investigational radiophar maceutical for targeting tumor-associated folate receptors. The kit co nsists of the DTPA-Folate conjugate in sodium citrate solution, from w hich [In-111]In-DTPA-Folate can be rapidly and reliably compounded by the addition of aqueous [In-111]In(III)-chloride.